Dose reduction or slower titration schedules can help manage symptoms whilst maintaining glycaemic control
In studies, after 52 weeks, participants on the highest dose of Mounjaro (15 mg per week): Lowered their total cholesterol by about 5.6 percent Lowered their triglycerides by 22.5 percent Lowered their LDL (bad) cholesterol by 7.9 percent Lowered their VLDL cholesterol by 21.8 percent Increased their HDL (good) cholesterol by 10.8 percent Additionally, a meta-analysis (analysis of data from several clinical trials) from The Lancet found that GLP-1 receptor agonist medications, including semaglutide (the active ingredient in Wegovy), lowered cardiovascular risk
Whether you take the pill or the shot, that work is what determines long-term outcomes
P., Torres-lvarez, B., Oros-Ovalle, C., Fuentes-Ahumada, C., Gonzlez, F